Prime Medicine, Inc. Common Stock
PRME
$2.88-0.86%
End of day · as of Sep 28, 2026, 6:32 PM ET
Mkt cap
$570.75M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$4.63M
EPS (TTM)
$-1.05
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-4342.44%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
Use this PRME research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PRME income, balance, and cash tables.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company in the Healthcare sector.
Latest cached Prime Medicine, Inc. Common Stock (PRME) revenue for Dec 31, 2025 was $4.6M. Net income was -$201.1M. Statements: https://lician.com/financials/prme
Prime Medicine, Inc. Common Stock (PRME) market capitalization is $570.8M on the latest cached snapshot.
Prime Medicine, Inc. Common Stock (PRME) cached previous close $2.90; day range $2.77 – $2.92; volume 3,671,504. Session quote: https://lician.com/quote/prme
Prime Medicine, Inc. Common Stock (PRME) latest cached earnings event is "PRME earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PRME filing is 8-K · Jul 8, 2026. Filings: https://lician.com/sec/prme